Could circulating progenitor cell count be a barometer for coronary artery disease progression?

Circulation Journal

Volumn 74, Issue 9, 2010, Pages 1804-1805

  Ae Park, Jeong ^a   Kwon, Young Guen ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY STENTING; CELL COUNT; CELL DAMAGE; CELL FUNCTION; CELL REGENERATION; CORONARY ARTERY DISEASE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART MUSCLE REVASCULARIZATION; HEMATOPOIETIC STEM CELL; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STABLE ANGINA PECTORIS; STEM CELL MOBILIZATION; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; BLOOD CELLS; CELL COUNT; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HUMANS; STEM CELLS;

EID: 77956127739     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0695     Document Type: Editorial

References (15)

1. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411-418.
2. Umemura T, Higashi Y. Endothelial progenitor cells: Therapeutic target for cardiovascular diseases. J Pharmacol Sci 2008; 108: 1-6.
3. Rodriguez-Losada N, Garcia-Pinilla JM, Jimenez-Navarro MF, Gonzalez FJ. Endothelial progenitor cells in cell-based therapy for cardiovascular disease. Cell Mol Biol 2008; 54: 11-23.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
5. Yoder MC. Defining human endothelial progenitor cells. J Thromb Haemost 2009; 7(Suppl 1): 49-52.
6. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
7. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
8. Ikeda N, Yasu T, Kubo N, Nakamura T, Sugawara Y, Ueda S, et al. Daily exercise and bone marrow-derived CD34+/133+ cells after myocardial infarction treated by bare metal stent implantation. Circ J 2008; 72: 897-901.
9. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovascular Research 2008; 78: 413-421.
10. Arao K, Yasu T, Ohmura N, Tsukamoto Y, Murata M, Kubo N, et al. Circulating CD34+/133+ progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention. Circ J 2010; 74: 1929-1935.
11. Eizawa T, Ikeda U, Murakami Y, Matsui K, Yoshioka T, Takahashi M, et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 2004; 90: 685-686.
12. Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006; 152: 190-195.
13. Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, et al. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J 2010; 24: 1981-1988.
14. Xiao Q, Kiechi S, Patel S, Oberhollenzer F, Weger S, Mayr A, et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis: Results from a large population-based study. PLoS One 2007; 2: e975.
15. Barsotti MC, Di Stefano R, Spontoni P, Chimenti D, Balbarini A. Role of endothelial progenitor cell mobilization after percutaneous angioplasty procedure. Curr Pharmaceut Des 2009; 15: 1107-1122.